Pharmaceutical Technology on MSN
Aktis Oncology kicks 2026 IPO cycle off with $210m target
"Aktis Oncology kicks 2026 IPO cycle off with $210m target" was originally created and published by Pharmaceutical Technology ...
After euphoric listings and sharp corrections, can India’s IPO market recalibrate valuations, protect retail capital, and ...
The recent IPO boom signals confidence in India’s economic story, but confidence should not slide into complacency ...
Kraken’s pending IPO and the wave of crypto companies seeking public listings may help the industry attract more TradFi capital. A potential initial public offering (IPO) next year by cryptocurrency ...
Kotak’s Sanjeev Prasad says only ’15-20% Of IPO funds used for asset creation’ — 5 key 2026 insights
IPO funds used mainly for promoter exits, not assets—see Sanjeev Prasad’s 2026 outlook and market drivers. Read key insights now!
Chairman Pandey says gaps in disclosures not only undermine investor understanding but can also prolong fund-raising ...
One of the biggest and best-performing crypto debuts was stablecoin issuer Circle Internet Group’s (CRCL) $1.05 billion debut ...
Over the next 18 months, more than 48 Indian startups are set to enter the public markets. The list includes some of the biggest unicorns in the country as well as startups across sectors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback